InsulinLisproQualityChecker

Insulin Lispro

API assay biologics biosimilars endotoxins fixed-dose combinations generics market map
Open selection

Insulin Lispro Quality Checker — Biologic Drug (Rapid-acting Insulin Analog) (Ph. Eur., USP)

ℹ️ The utility checks potency, proinsulin, aggregates, zinc, preservatives, sterility, endotoxins.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! Proinsulin ≤10 ppm, Aggregates ≤0.5%, Sterility mandatory!

Usage:
InsulinLisproQualityChecker.exe → demo mode
InsulinLisproQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Meta_Cresol_Content_Percent,Phenol_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score

Example:
INS-LIS-2026-001,3.5,27.0,100.0,7.2,0.04,0.16,0.0,2.5,0.3,0.1,1.0,2.0,0,0.02,0

— WHY IS THIS NEEDED?
Insulin Lispro — rapid-acting human insulin analog (LysB28-ProB29 swapped to ProB28-LysB29):
• Potency (IU): Key efficacy parameter. Determined by bioassay. Dosing error is fatal.
• Proinsulin: Precursor. Causes antibody formation. Limit is extremely strict (<10 ppm).
• Aggregates (HMW): High molecular weight proteins cause immune response and loss of activity.
• Zinc: Required for stable hexamer formation in vial/cartridge.
• Meta-Cresol/Phenol: Preservatives required for multi-dose vials. Concentration must be in strict range.
• Sterility and Endotoxins: Absolutely mandatory for parenteral administration.
⚠️ CRITICAL:
• Protein Concentration: 3.4–3.6 mg/mL (for U-100)
• Specific Potency: 26–28 IU/mg
• Proinsulin: ≤ 10 ppm
• Aggregates (HMW): ≤ 0.5%
• Zinc: 0.03–0.06%
• Meta-Cresol: 0.15–0.25% (typical range)
• Sterility: No growth
• Endotoxins: ≤ 0.5 EU/mL
• Appearance: Clear, colorless, particle-free
⚠️ Note: Utility combines data from bioassay, HPLC (proinsulin, related proteins), AAS (zinc), and microbiology. For insulin lispro, proinsulin and aggregate control are Critical Quality Attributes (CQA) as they directly affect drug immunogenicity. Any deviation in sterility or appearance leads to immediate batch rejection. Preservative control important for safety and stability of multi-dose forms.

input.csv

BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Meta_Cresol_Content_Percent,Phenol_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score
INS-LIS-2026-001,3.5,27.0,100.0,7.2,0.04,0.16,0.0,2.5,0.3,0.1,1.0,2.0,0,0.02,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: InsulinLisproQualityCheckerAPI / object: Insulin LisproCategory: Global API

1. Scope

The Insulin Lispro Quality Checker utility is used for Insulin Lispro. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API

Tags: API, assay, biologics, biosimilars, endotoxins, fixed-dose combinations, generics, market map, microbiology, sterility

2. Execution modes

InsulinLisproQualityChecker.exe                            → demo mode
InsulinLisproQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • microbiology and pathogens
  • pH and physicochemical parameters

4. Domain limits and critical parameters

  • ⚠️ CRITICAL! Proinsulin ≤10 ppm, Aggregates ≤0.5%, Sterility mandatory!
  • Proinsulin: Precursor. Causes antibody formation. Limit is extremely strict (<10 ppm).
  • ⚠️ CRITICAL:
  • Protein Concentration: 3.4–3.6 mg/mL (for U-100)
  • Specific Potency: 26–28 IU/mg
  • Proinsulin: ≤ 10 ppm
  • Aggregates (HMW): ≤ 0.5%
  • Zinc: 0.03–0.06%
  • Meta-Cresol: 0.15–0.25% (typical range)
  • Sterility: No growth
  • Endotoxins: ≤ 0.5 EU/mL
  • Appearance: Clear, colorless, particle-free
  • ⚠️ Note: Utility combines data from bioassay, HPLC (proinsulin, related proteins), AAS (zinc), and microbiology. For insulin lispro, proinsulin and aggregate control are Critical Quality Attributes (CQA) as they directly affect drug immunogenicity. Any deviation in sterility or appearance leads to immediate batch rejection. Preservative control important for safety and stability of multi-dose forms.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Insulin Lispro with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, microbiology and pathogens, pH and physicochemical parameters.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberINS-LIS-2026-001mandatory field; used for batch/lot traceability
2Protein_Concentration_mgPerMldecimalmg/mlProtein Concentration mg per Ml3.5numeric value; compared with assay/purity limit from specification or method
3Potency_IU_per_mgdecimalas specifiedPotency IU per mg27.0mandatory numeric value; rule comparison is performed by the utility
4Total_Potency_IU_per_mldecimalIU/mlTotal Potency IU per ml100.0mandatory numeric value; rule comparison is performed by the utility
5pH_ValuedecimalpHp H Value7.2mandatory numeric value; rule comparison is performed by the utility
6Zinc_Content_Percentdecimal%Zinc Content %0.04numeric value; compared with assay/purity limit from specification or method
7Meta_Cresol_Content_Percentdecimal%Meta Cresol Content %0.16numeric value; compared with assay/purity limit from specification or method
8Phenol_Content_Percentdecimal%Phenol Content %0.0numeric value; compared with assay/purity limit from specification or method
9Proinsulin_Content_ppmdecimalppmProinsulin Content ppm2.5numeric value; compared with assay/purity limit from specification or method
10Related_Proteins_Percentdecimal%Related Proteins %0.3numeric value; compared with individual or total impurity limit
11High_Molecular_Weight_Proteins_Percentdecimal%High Molecular Weight Proteins %0.1mandatory numeric value; rule comparison is performed by the utility
12Residual_DNA_ngPerMldecimalas specifiedResidual DNA ng per Ml1.0mandatory numeric value; rule comparison is performed by the utility
13Host_Cell_Protein_ppmdecimalppmHost Cell Protein ppm2.0mandatory numeric value; rule comparison is performed by the utility
14SterilityTestboolean / flag0/1Sterility Test0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
15Endotoxin_EU_mldecimalas specifiedEndotoxin EU ml0.02numeric value; critical safety attribute compared with endotoxin limit
16Appearance_Scoredecimalas specifiedAppearance Score0mandatory numeric value; rule comparison is performed by the utility

CSV example

BatchNumber,Protein_Concentration_mgPerMl,Potency_IU_per_mg,Total_Potency_IU_per_ml,pH_Value,Zinc_Content_Percent,Meta_Cresol_Content_Percent,Phenol_Content_Percent,Proinsulin_Content_ppm,Related_Proteins_Percent,High_Molecular_Weight_Proteins_Percent,Residual_DNA_ngPerMl,Host_Cell_Protein_ppm,SterilityTest,Endotoxin_EU_ml,Appearance_Score
INS-LIS-2026-001,3.5,27.0,100.0,7.2,0.04,0.16,0.0,2.5,0.3,0.1,1.0,2.0,0,0.02,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable InsulinLisproQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Insulin Lispro, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "InsulinLisproQualityChecker",
  "api": "Insulin Lispro",
  "batchNumber": "INS-LIS-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "INS-LIS-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Protein_Concentration_mgPerMl",
      "value": "3.5",
      "unit": "mg/ml",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Potency_IU_per_mg",
      "value": "27.0",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Total_Potency_IU_per_ml",
      "value": "100.0",
      "unit": "IU/ml",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH_Value",
      "value": "7.2",
      "unit": "pH",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Zinc_Content_Percent",
      "value": "0.04",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Meta_Cresol_Content_Percent",
      "value": "0.16",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Phenol_Content_Percent",
      "value": "0.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Australia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Bangladesh: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Biopharmaceuticals Core QC Suite

Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.

Open

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Canada: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Democratic Republic of the Congo: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Diabetes QC Suite

QC package for diabetes medicines: insulins, metformin, SGLT2/DPP-4/GLP-1 products, glucagon and supporting dosage-form quality checks.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Ethiopia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

France: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Germany: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Global API & Biosimilars QC Suite

Package for high-demand global APIs, generics and biosimilars, including fixed-dose combinations and biological products.

Open

Immunology QC Suite

QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.

Open

India: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Indonesia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Italy: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Japan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Kenya: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Myanmar: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Nigeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Pakistan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Africa: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

South Korea: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Sudan: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Tanzania: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Uganda: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United Kingdom: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open